6-K ·Filed Jun 3, 2026

RDY

DR REDDYS LABORATORIES LTD
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001575872-26-000395
Notable filing: 6-K
Actionable Insight • Neutral

No actionable trading signal — this is a routine investor relations update. Monitor for any material disclosures that may emerge from the conferences, but no immediate action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
RDY ▼ -6.61% at T+60d
NEUTRAL call ✗ call lost -6.61% · α vs SPY -9.10% · entry $13.02 → $12.16
Entry anchored
Jun 3, 2026
via day open
T+1d
+1.69%
call +1.69% · α +1.29%
$13.24
settled 4mo ago
T+5d
+2.15%
call +2.15% · α +5.97%
$13.30
settled 4mo ago
T+20d
+10.45%
call +10.45% · α +11.45%
$14.38
settled 3mo ago
T+60d
-6.61%
call -6.61% · α -9.10%
$12.16
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Dr. Reddy's filed a Form 6-K on June 3, 2026, disclosing that management will participate in two investor conferences: a group meeting organized by ICICI Securities in Mumbai on June 9, 2026, and a group meeting organized by Macquarie in Hyderabad on June 10, 2026. This is a routine disclosure of investor relations activities with no material financial information.

Key Facts

  • Management to participate in ICICI Securities group meeting in Mumbai on June 9, 2026
  • Management to participate in Macquarie group meeting in Hyderabad on June 10, 2026
  • Both meetings are in-person group meetings with institutional investors
  • No material financial data, guidance, or business developments disclosed

Financial Impact

No financial impact — routine investor conference participation with no material disclosures

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
52% bullish (44 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001575872-26-000395
Document: 0001575872-26-000395-index.html0001575872-26-000395
Document: 0001575872-26-000395.txt0001575872-26-000395
51 reports for RDY
Performance horizon
67% Hit rate 6 of 9 directional calls best @ T+20▲ +23.28%Jun 26, 2026
Filters
Rows
Reports for RDY — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
6-K
NEUTRAL ★ 3/10
$11.91 $11.55▼ −3.02%▼ −2.56%$12.25 (+2.85%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 5/10
$11.71 $11.90▲ +1.62%▲ +0.77%$12.25 (+4.61%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 2/10
$11.71 $11.90▲ +1.62%▲ +0.77%$12.25 (+4.61%)
Aug 26, 2026
5w ago
6-K
NEUTRAL ★ 2/10
$12.22 $12.16▼ −0.49%▼ −1.15%$12.25 (+0.25%)
Aug 17, 2026
6w ago
6-K
MIXED ★ 5/10
$12.11 $12.15▲ +0.33%▲ +1.01%$12.25 (+1.16%)
Aug 13, 2026
7w ago
6-K
NEUTRAL ★ 3/10
$12.42 $12.27▼ −1.21%▼ −1.01%$12.25 (−1.37%)
Aug 10, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$12.15 $12.45▲ +2.47%▲ +2.79%$12.25 (+0.82%)
Aug 3, 2026
8w ago
6-K
BULLISH ★ 6/10
$12.07 $12.10▲ +0.25%▼ −1.55%$12.25 (+1.49%)
Jul 29, 2026
9w ago
6-K
NEUTRAL ★ 4/10
$11.76 $11.83▲ +0.60%▼ −1.08%$12.25 (+4.17%)
Jul 23, 2026
10w ago
6-K
NEUTRAL ★ 2/10
$11.80 $11.79▼ −0.08%▼ −0.19%$12.25 (+3.81%)
Showing 10 of 51

US Market Status

Market Closed — Opens Mon (65h 26m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access